China Isotope & Radiation Corp
HKEX:1763
China Isotope & Radiation Corp
Total Liabilities & Equity
China Isotope & Radiation Corp
Total Liabilities & Equity Peer Comparison
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
China Isotope & Radiation Corp
HKEX:1763
|
Total Liabilities & Equity
¥13.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Total Liabilities & Equity
¥33.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Total Liabilities & Equity
¥9.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Total Liabilities & Equity
¥11.6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Total Liabilities & Equity
¥17.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Total Liabilities & Equity
¥8.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
See Also
What is China Isotope & Radiation Corp's Total Liabilities & Equity?
Total Liabilities & Equity
13.2B
CNY
Based on the financial report for Dec 31, 2023, China Isotope & Radiation Corp's Total Liabilities & Equity amounts to 13.2B CNY.
What is China Isotope & Radiation Corp's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
14%
Over the last year, the Total Liabilities & Equity growth was 12%. The average annual Total Liabilities & Equity growth rates for China Isotope & Radiation Corp have been 13% over the past three years , 14% over the past five years .